Ishita Drugs and Industries Limited (BOM:524400)
70.00
0.00 (0.00%)
At close: Jan 22, 2026
BOM:524400 Market Cap
BOM:524400 has a market cap or net worth of 209.32 million as of January 23, 2026. Its market cap has decreased by -18.60% in one year.
Market Cap
209.32M
Enterprise Value
122.35M
Revenue
171.64M
Ranking
n/a
PE Ratio
21.53
Stock Price
70.00
Market Cap Chart
Since May 24, 2005, BOM:524400's market cap has increased from 25.69M to 209.32M, an increase of 714.90%. That is a compound annual growth rate of 10.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 209.32M | -12.50% |
| Dec 31, 2025 | 239.22M | -13.45% |
| Dec 31, 2024 | 276.39M | 28.48% |
| Dec 29, 2023 | 215.12M | 39.01% |
| Dec 30, 2022 | 154.75M | 11.89% |
| Dec 31, 2021 | 138.30M | 41.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Auro Laboratories | 1.34B |
| Krebs Biochemicals & Industries | 1.30B |
| Tyche Industries | 1.18B |
| Resonance Specialties | 1.15B |
| Bacil Pharma | 616.32M |
| Vasundhara Rasayans | 475.94M |
| Supha Pharmachem | 342.72M |
| Crestchem | 268.50M |